Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Noribogaine HCl safe and well tolerated in healthy volunteers

Dec. 12, 2014

Researchers present novel radiomitigating compounds

Nov. 28, 2014

PRO-028 and PRO-027: novel NAC analogues for cocaine addiction

Nov. 26, 2014

RGFP-966, an epigenetic HDAC3 inhibitor, tested in a rat cocaine-abuse model

Nov. 17, 2014

Eisai and Arena report phase II data for lorcaserin in smoking cessation

Nov. 4, 2014

Orexo applies to FDA to expand Zubsolv label to include initiation of opioid dependence therapy

Oct. 13, 2014

Japanese approval for fomepizole to treat ethylene glycol and methanol poisonings

Sep. 26, 2014

Soligenix awarded NIAID contract to develop heat stable RiVax vaccine

Sep. 23, 2014

Legalon Sil given FDA orphan designation for amatoxin poisoning

Sep. 22, 2014

Cellerant's development of CLT-008 supported by additional government funding

Sep. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...